新京报讯(记者左琳)9月29日晚，河南省鹤壁市山城区应急管理局通报一起有害气体中毒事件，目前已 有5人经抢救无效死亡，1人重伤、生命体征平稳，2人轻伤。9月30日中午，现场一位负责人告诉新京报 记者，当地工作人员仍在处置，企业负责人正在协助调查具体原因，其他情况要等专家组的调查结果。 记者注意到，该企业近年曾多次受到安全及环保处罚。 2018年，中央生态环境保护督察组曾公示，涉事企业被举报大量排放污水，造成附近养鱼户26万斤活鱼 死亡，经调查核实，发现其厂区部分生产设备存在"跑冒滴漏"等问题，山城区环保局责令企业七日内完 成问题整改，并对其违法行为进行了立案处罚。 2022年1月，该企业因2号吸收槽密闭不严，间歇性有气体溢出，1号换热器顶部密闭不严，间歇性有气 体溢出，沸腾炉下部、静电除尘器平台有废渣，设备密闭不严而被鹤壁市生态环境局责令改正；2022年 7月，该企业因排放的大气污染物，经在线监测采样监测，颗粒物日均值项污染物超过单位执行标准的 0.59倍，再次被鹤壁市生态环境局责令改正；今年5月，山城区应急局执法人员检查时发现该企业存在 硫酸罐区部分管道无介质流向标识隐患，要求其立即整改，企业当天整改完毕。 ...

Core Viewpoint - The company, Andisu, is progressing with its private placement fundraising project, aiming to raise up to 3 billion yuan for various strategic initiatives, including functional and specialty product projects, sustainable development, and working capital [1][2]. Group 1: Fundraising and Strategic Development - The private placement aims to raise a total of no more than 3 billion yuan, with net proceeds allocated to functional products, specialty products, sustainable development projects, and working capital [2][3]. - The company has categorized its main business products into functional products, which include methionine, vitamins, and ammonium sulfate, and specialty products, which focus on enhancing animal health and feed quality [2][3]. Group 2: Financial Performance and Recovery - After experiencing a significant decline in performance in 2022 and 2023, the company is expected to return to normal operations in 2024, with projected revenues of 15.534 billion yuan and a net profit of 1.204 billion yuan [1][6]. - The company reported a 24% increase in revenue from functional products in 2024, achieving 11.622 billion yuan, while specialty products generated 3.913 billion yuan, reflecting a 4% growth [2][5]. - The company’s net profit for 2024 is projected to increase by 2208.66% compared to the previous year, indicating a strong recovery [6]. Group 3: Market Position and Growth - The company has increased its market share in methionine from 23% in 2012 to 28% in 2023, solidifying its leadership position in the industry [5]. - The company is expanding its global market presence, with double-digit sales growth in Europe, North America, and Asia in 2024 [3]. - The price of methionine has risen by approximately 8.14% since 2025, which is expected to positively impact the company's performance [3].